AUS
NZ
UK
CA
USA
IND
_06_19_2026_12_34_15_139937.jpg)
Highlights
- Data infrastructure rising on AI and cloud trends
- Medical imaging software expanding global footprint
- Sleep health innovator tapping into massive global demand
Investors seeking exposure to long-term growth potential in the ASX market may find compelling opportunities in a few standout businesses with resilient strategies and exposure to structural trends. As the broader ASX 200 share price continues to demonstrate strength, attention has turned to companies with unique market positioning and long-term upside.
NextDC (ASX:NXT)
NextDC is at the forefront of Australia’s digital infrastructure, operating an extensive network of Tier III and Tier IV data centres nationwide. These facilities support enterprise and government clients by delivering secure, energy-efficient services. What makes NextDC distinctive is its rich connectivity ecosystem – a digital crossroads linking hundreds of IT service providers, networks, and cloud platforms. With increasing demand for AI processing, sovereign data storage, and digital transformation, the company is strategically positioned to benefit from the surging need for scalable data capacity.
Pro Medicus (ASX:PME)
This healthcare technology firm is making waves in diagnostic imaging with its advanced Visage 7 platform. Designed to improve the speed and accuracy of radiology interpretations, this software enhances workflows and outcomes for healthcare providers. Pro Medicus draws the majority of its revenue from international markets, especially the US, through long-term enterprise contracts. With expansion into new domains such as cardiology and a growing global pipeline, the company continues to solidify its position as a high-impact innovator in the medical software space.
ResMed (ASX:RMD)
A pioneer in respiratory health, ResMed has built a global presence focused on addressing sleep apnoea and related disorders. Its strategic roadmap through 2030 is centred around AI-powered connected health platforms, aiming to enhance quality of life for millions affected by sleep issues. The company continues to invest heavily in research and development to sustain its technological edge. With a vast untapped global population impacted by sleep and breathing challenges, ResMed’s potential runway for growth remains expansive.
These companies are not only part of the ASX 200 index but also represent sectors with secular tailwinds. Their ability to innovate, scale, and maintain competitive advantages positions them well for performance over the coming decade. Investors looking at the ASX for long-term conviction may find these names worthy of deeper attention as structural shifts continue to reshape industries.
